Trial
NCT01499160
Letrozole and Lapatinib Followed by Everolimus in Women With Advanced Breast Cancer
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
University of Maryland, Baltimore
Collaborators
Novartis Pharmaceuticals; GlaxoSmithKline
Condition
Breast Neoplasms
Intervention
letrozole
Why stopped
low accrual
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2022-02-11